Telehealth roll-ups and platform acquisitions have kept closing through 2026, often faster than the regulatory diligence that should precede them. A buyer who skips licensure, platform-contract, and billing review does not just acquire a functioning telehealth practice. It acquires every unresolved state licensure gap, every unfavorable platform term, and every dollar of billing exposure the seller has not yet reported. Under 42 CFR 489.18, an acquired practice's Medicare provider agreement, and the liabilities attached to it, can transfer to the buyer by operation of law.
Licensure Gaps That Survive The Closing
A telehealth clinician generally must hold an active license in the state where the patient is located at the time of the encounter, not only the state where the clinician or the platform is based. A multi-state telehealth practice can look fully licensed on its organizational chart and still have individual clinicians seeing patients in states where they never registered. The Interstate Medical Licensure Compact speeds physician licensure across more than 40 member states, but compact membership does not cover every clinician type on a telehealth platform, and nurse practitioners and physician assistants often hold separate, less complete multi-state credentials. Buyers should confirm, encounter by encounter where possible, that every treating clinician held a valid license for the patient's state, not just the platform's state of registration.
Platform Contracts And Inherited Terms
Most telehealth practices operate under a management services agreement that structures billing support, marketing, and clinical staffing through a platform or MSO. Diligence has to confirm the agreement is assignable on a change of control, and that it complies with the corporate practice of medicine restrictions several states tightened for 2026: California's SB 351 and AB 1415 and Oregon's SB 951 all took effect January 1, 2026 and restrict a non-physician investor's control over clinical decision-making, scheduling, compensation, and payer terms. A marketing or lead-generation arrangement that pays the platform based on referral or prescription volume raises anti-kickback statute exposure that follows the practice into the new ownership, the pattern the firm has covered in marketing arrangements in telehealth.
Billing Exposure That Transfers With The Practice
In a stock purchase, the buyer inherits the seller's full billing history, including any overpayment the seller has not yet reported. Under the 60-day rule, 42 U.S.C. § 1320a-7k(d), retaining a known overpayment past 60 days becomes an obligation under the reverse false claims act provision, 31 U.S.C. § 3729(b)(3), exposing the new owner to treble damages on claims it never submitted. In an asset purchase, the buyer chooses whether to accept automatic assignment of the Medicare provider agreement under 42 CFR 489.18; accepting it avoids a billing gap but carries the seller's overpayment and sanction exposure forward, while declining it means re-enrolling as a new applicant. A claims-data review that surfaces prescribing patterns tied to prior recoupment demands, the exposure the firm has covered in when auditors pull telehealth prescribing records, belongs in diligence alongside the financial statements.
A platform contract that complied with corporate practice of medicine rules in 2024 may violate the MSO restrictions that took effect January 1, 2026, and the buyer inherits that violation at closing.
Why Early Legal Counsel Is Critical
It is critical that a buyer or seller retain experienced healthcare defense counsel before a telehealth acquisition reaches signature, not after a licensure gap or a billing overpayment surfaces post-close. Early legal involvement can confirm which clinicians and platform terms carry regulatory exposure, structure the deal as an asset or stock purchase to contain that exposure deliberately rather than by default, and resolve a licensure gap or an unreported overpayment before it becomes the buyer's problem. Delaying legal review until after closing can turn a fixable diligence gap into inherited liability the buyer never priced into the deal.
How Health Law Alliance Can Help
Health Law Alliance advises telehealth providers and platforms nationwide on acquisitions, from licensure and corporate-practice-of-medicine review to platform-contract diligence and inherited billing exposure. Our telehealth law and telemedicine attorneys draw on the firm's coverage of telehealth licensure enforcement across state lines to size a deal's regulatory exposure before it closes rather than after. Health Law Alliance has represented 2,500+ clients over 25+ years, including telehealth practices and platforms navigating acquisitions. If you are buying, selling, or being acquired, contact us for a free, confidential consultation.
